Arie Gluzman, MD
Pain Medicine · Newport Beach, CANPI 1528179017
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,599 of the $1,782 with a category attached, or 89.7%. 20 manufacturers reported payments, led by AbbVie at 42.3% of the total. Reporting peaked in 2022 at $548 and has fallen 72.5% since, to $150 in 2025. That places this record below the midpoint for pain medicine clinicians in CA, where the typical reported total is $1,829.
Across 69 payments — averaging $25.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$753
- Medtronic$162
- SPR Therapeutics, Inc$110
- Curonix LLC$105
- Collegium Pharmaceutical, Inc.$102
- Pfizer$76
- plus $474 from 14 others
What the payments were for
- Grants$1629%
- Food & beverage$1,59990%
- Education$211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 34 | $753 |
| Medtronic | 1 | $162 |
| SPR Therapeutics, Inc | 3 | $110 |
| Curonix LLC | 4 | $105 |
| Collegium Pharmaceutical, Inc. | 3 | $102 |
| Pfizer | 4 | $76 |
| Biodelivery Sciences International, Inc. | 1 | $73 |
| Stimwave Technologies Incorporated | 3 | $64 |
| Bioventus LLC | 2 | $52 |
| Ossur Americas, Inc. | 1 | $46 |
| Electronic Waveform Lab, Inc. | 3 | $42 |
| Lilly USA, LLC | 2 | $36 |
| Amgen | 1 | $26 |
| Nevro Corp. | 1 | $24 |
| Hikma Pharmaceuticals USA | 1 | $21 |
| GRT US Holding, Inc. | 1 | $19 |
| Valinor Pharma, LLC | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $18 |
| Forte Bio-pharma LLC | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,782 in reported general payments places this provider in the 45th percentile of 840 pain medicine providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 32 | $15,921 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 444 | $12,814 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 232 | $7,336 |
| NeurontinGabapentin | 11 | $5,766 |
| Lidocaine | 43 | $5,024 |
| Gabapentin | 99 | $2,343 |
| Pregabalin | 97 | $2,239 |
| Tramadol Hcl | 143 | $2,140 |
| Morphine Sulfate ErMorphine Sulfate | 41 | $1,576 |
| Naloxone Hcl | 31 | $1,573 |
| Oxycodone Hcl | 95 | $1,383 |
| Fentanyl | 11 | $1,245 |
| Diclofenac Sodium | 17 | $1,157 |
| Methocarbamol | 76 | $801 |
| Cyclobenzaprine Hcl | 48 | $392 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Newport Beach
- Richard PaiciusNewport Beach$194K
- Jason PopeSanta Rosa$2.1M
- Ramana NaiduLarkspur$1.4M
- Foead GeulaStudio City$1.3M
- Krishnan ChakravarthyTemecula$1.3M
- Kasra AmirdelfanWalnut Creek$783K
- Eric GrigsbyNapa$499K
- Jacqueline WeisbeinNapa$494K
- Gerald SacksSanta Monica$389K
- Samir ShethRoseville$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.